Combination Therapy for Extreme Drug-Resistant Acinetobacter baumannii: Ready for Prime Time?

Affiliations

¹ Division of Infectious Diseases, Keck School of Medicine at USC and the Los Angeles County-USC Medical Center, Los Angeles, CA Department of Medicine, Department of Pharmacology, Department of Molecular Biology and Microbiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH.

Editorial

Brad Spellberg et al. Crit Care Med. 2015 Jun.

. 2015 Jun;43(6):1332-4.

doi: 10.1097/CCM.0000000000001029.

¹ Division of Infectious Diseases, Keck School of Medicine at USC and the Los Angeles County-USC Medical Center, Los Angeles, CA Department of Medicine, Department of Pharmacology, Department of Molecular Biology and Microbiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH.

No abstract available

Comment on

Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
Cheng A, Chuang YC, Sun HY, Sheng WH, Yang CJ, Liao CH, Hsueh PR, Yang JL, Shen NJ, Wang JT, Hung CC, Chen YC, Chang SC. Cheng A, et al. Crit Care Med. 2015 Jun;43(6):1194-204. doi: 10.1097/CCM.0000000000000933. Crit Care Med. 2015. PMID: 25793437

1. Shlaes DM, Sahm D, Opiela C, et al. Commentary: The FDA Reboot of Antibiotic Development. Antimicrob Agents Chemother. 2013;57:4605–4607. - PMC - PubMed
1. Infectious Diseases Society of A White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens. Clin Infect Dis. 2012;55(8):1031–1046. - PMC - PubMed
1. Park YK, Peck KR, Cheong HS, et al. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea. Emerg Infect Dis. 2009;15(8):1325–1327. - PMC - PubMed
1. Tseng YC, Wang JT, Wu FL, et al. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2007;59(2):181–190. - PubMed
1. Metan G, Sariguzel F, Sumerkan B. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur J Intern Med. 2009;20(5):540–544. - PubMed